EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial

Yves Reznik iD, Martin Carvalho, Salha Fendri, Gaetan Prevost, Lucy Chaillous, Jean Pierre Riveline, Hélène Hanaire iD, Séverine Dubois, Patrick Houéto, Hélène Pasche, Beata Mianowska iD, Eric Renard iD

Diabetes, Obesity and Metabolism · 2024-02 · 26 (2) · 622-630

DOI: 10.1111/dom.15351 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 03.11.2023. Verfasst von Yves Reznik und 11 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France and Unicaen, Caen Cedex, France. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Hypoglycemia, Home Care Services. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Air Liquide Sante International, European Institute of Innovation and Technology, H2020 European Institute of Innovation and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The study aim was to evaluate the feasibility, safety and efficacy of automated insulin delivery (AID) assisted by home health care (HHC) services in people with type 2 diabetes unable to manage multiple daily insulin injections (MDI) at home on their own. Patients and Methods This was an open label, multicentre, randomized, parallel group trial. In total, 30 adults with type 2 diabetes using MDI and requiring nursing support were randomly allocated to AID or kept their usual therapy over a 12‐week period. Both treatments were managed with the support of HHC services. The primary outcome was the percentage time in the target glucose range of 70‐180 mg/dl (TIR). Secondary outcomes included other continuous glucose monitoring metrics, glycated haemoglobin (HbA1c) levels, daily insulin doses, body weight, and of quality of life scores, fear of hypoglycaemia and satisfaction questionnaires.

Results

Age (69.7 vs. 69.3 years) and HbA1c (9.25 vs. 9.0) did not differ in MDI and AID at baseline. Compared with MDI, AID resulted in a significant increase in TIR by 27.4% [95% CI (15.0‐39.8); p < .001], a decrease in time above range by 27.7% and an unchanged time below range of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2HypoglycemiaHome Care ServicesAdultHumansInsulinHypoglycemic AgentsGlycated HemoglobinBlood Glucose Self-MonitoringQuality of LifeBlood GlucoseTreatment OutcomeInsulin Infusion SystemsInsulin, Regular, Human

Stichwörter der Autor:innen

automated insulin deliveryhybrid closed looptype 2 diabetes

Substanzen

InsulinHypoglycemic AgentsGlycated HemoglobinBlood GlucoseInsulin, Regular, Human

Autor:innen und Institutionen

  • Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France and Unicaen, Caen Cedex, France.
  • Diabetology Department, Vert Coteau Clinic, Marseille, France.
  • Diabetology Department, Amiens University Hospital, Amiens, France.
  • Normandie Univ, UNIROUEN, Inserm U1239, CHU Rouen, Department of Endocrinology, Diabetes and metabolic diseases and Inserm CIC-CRB 140, Rouen, France.
  • Diabetology Department, Nantes University Hospital, Nantes, France.
  • Centre Universitaire du diabète et de ses complications, APHP, Hôpital Lariboisière, Paris, Île-de-France, France and Institut Necker Enfants Malades, INSERM U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Paris, France.

ORCID-Profile: Yves Reznik, Hélène Hanaire, Beata Mianowska, Eric Renard

Förderung

  • Air Liquide Sante International
  • European Institute of Innovation and Technology
  • H2020 European Institute of Innovation and Technology

Zitieren

APA

Reznik, Y., Carvalho, M., Fendri, S., Prevost, G., Chaillous, L., Riveline, J. P., Hanaire, H., Dubois, S., Houéto, P., Pasche, H., Mianowska, B., & Renard, E. (2024). Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial. Diabetes, Obesity and Metabolism, 26(2), 622-630. https://doi.org/10.1111/dom.15351

Vancouver

Reznik Y, Carvalho M, Fendri S, Prevost G, Chaillous L, Riveline JP, et al. Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial. Diabetes, Obesity and Metabolism. 2024;26(2):622-630. doi:10.1111/dom.15351

BibTeX
@article{Reznik2024,
  author = {Reznik, Yves and Carvalho, Martin and Fendri, Salha and Prevost, Gaetan and Chaillous, Lucy and Riveline, Jean Pierre and Hanaire, Hélène and Dubois, Séverine and Houéto, Patrick and Pasche, Hélène and Mianowska, Beata and Renard, Eric},
  title = {Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {2},
  pages = {622--630},
  doi = {10.1111/dom.15351}
}
Kostenlos starten →